Prognostic values of Notch receptors in breast cancer
- PMID: 26323259
- DOI: 10.1007/s13277-015-3961-6
Prognostic values of Notch receptors in breast cancer
Abstract
Notch receptors are frequently deregulated in several human malignancies including human breast cancer. Activation of Notch has been reported to cause mammary carcinomas in mice. However, the prognostic value of individual Notch receptors in breast cancer (BC) patients remains elusive. In the current study, we investigated the prognostic value of Notch receptors in human BC patients. More specifically, we investigated the prognostic value of four Notch receptors in breast cancer patients through "the Kaplan-Meier plotter" (KM plotter) database, in which updated gene expression data and survival information are from a total of 3554 breast cancer patients. Our results showed that Notch1 messenger RNA (mRNA) high expression was correlated to worsen overall survival (OS) in PgR-negative BC patients. Notch2, Notch3, and Notch4 mRNA high expressions were found to be correlated to better OS for all breast cancer patients. Notch2 was also found to be correlated to better OS in lymph node-negative breast cancer patients and HER2-positive breast cancer patients. These results will be useful for better understanding of the heterogeneity and complexity in the molecular biology of breast cancer and for developing tools to more accurately predict their prognosis and design their customized treatment strategies.
Keywords: Estrogen receptor (ER); Hazardous ratio (HR); KM plotter; Notch receptor; Prognosis.
Similar articles
-
Distinct prognostic values of four-Notch-receptor mRNA expression in ovarian cancer.Tumour Biol. 2016 May;37(5):6979-85. doi: 10.1007/s13277-015-4594-5. Epub 2015 Dec 12. Tumour Biol. 2016. PMID: 26662955
-
Prognostic roles of mRNA expression of notch receptors in non-small cell lung cancer.Oncotarget. 2017 Feb 21;8(8):13157-13165. doi: 10.18632/oncotarget.14483. Oncotarget. 2017. PMID: 28061457 Free PMC article.
-
Prognostic roles of Notch receptor mRNA expression in human ovarian cancer.Oncotarget. 2017 May 16;8(20):32731-32740. doi: 10.18632/oncotarget.16387. Oncotarget. 2017. PMID: 28415574 Free PMC article.
-
The multigene classifiers 95GC/42GC/155GC for precision medicine in ER-positive HER2-negative early breast cancer.Cancer Sci. 2021 Apr;112(4):1369-1375. doi: 10.1111/cas.14838. Epub 2021 Feb 26. Cancer Sci. 2021. PMID: 33544932 Free PMC article. Review.
-
The role of molecular analysis in breast cancer.Pathology. 2009 Jan;41(1):77-88. doi: 10.1080/00313020802563536. Pathology. 2009. PMID: 19089743 Review.
Cited by
-
Developmental signaling pathways regulating mammary stem cells and contributing to the etiology of triple-negative breast cancer.Breast Cancer Res Treat. 2016 Apr;156(2):211-26. doi: 10.1007/s10549-016-3746-7. Epub 2016 Mar 11. Breast Cancer Res Treat. 2016. PMID: 26968398 Free PMC article. Review.
-
The many facets of Notch signaling in breast cancer: toward overcoming therapeutic resistance.Genes Dev. 2020 Nov 1;34(21-22):1422-1438. doi: 10.1101/gad.342287.120. Genes Dev. 2020. PMID: 33872192 Free PMC article. Review.
-
Molecular Mechanisms Associated with Brain Metastases in HER2-Positive and Triple Negative Breast Cancers.Cancers (Basel). 2021 Aug 17;13(16):4137. doi: 10.3390/cancers13164137. Cancers (Basel). 2021. PMID: 34439289 Free PMC article. Review.
-
Therapeutic and Prognostic Relevance of Cancer Stem Cell Populations in Endometrial Cancer: A Narrative Review.Diagnostics (Basel). 2025 Jul 25;15(15):1872. doi: 10.3390/diagnostics15151872. Diagnostics (Basel). 2025. PMID: 40804837 Free PMC article. Review.
-
Prognostic values of F-box members in breast cancer: an online database analysis and literature review.Biosci Rep. 2019 Jan 3;39(1):BSR20180949. doi: 10.1042/BSR20180949. Print 2019 Jan 31. Biosci Rep. 2019. PMID: 30341246 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous